Chemours Q1 FY26 net loss widens to $29 million; net sales rise 1% to $1.4 billion

Chemours Co.

Chemours Co.

CC

0.00

  • Chemours posted Q1 2026 net sales of $1.4 billion, up 1% year over year, while net loss attributable to shareholders widened to $29 million from $5 million.
  • Loss per share widened to $0.19 from $0.03; adjusted EBITDA edged up 2% to $169 million.
  • Thermal & Specialized Solutions net sales climbed 22% to $568 million, while Titanium Technologies fell 6% to $559 million; Advanced Performance Materials dropped 17% to $243 million.
  • Completed sale of nine of 10 Kuan Yin land parcels, receiving about $287 million in initial net proceeds; used part of proceeds and cash on hand to pay down EUR 140 million of Euro term loans due August 2028.
  • Forecasts Q2 adjusted EBITDA of $220 million-$250 million on sequential net sales growth of 15%-20%; maintains 2026 adjusted EBITDA outlook of $800 million-$900 million with net sales growth of 3%-5%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Chemours Company published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605051658PR_NEWS_USPR_____PH51835) on May 05, 2026, and is solely responsible for the information contained therein.